One of the latter two TCGA studies did not use proteomics (99), whereas the other study (95) explored 57 carcinosarcomas and -also in this case-, protein analyses were used to confirm other features identified with the molecular analyses (like EMT transitions, PI3K/AKT pathway activation, low steroid hormone receptor signalling). Here, AKT1 is linked to carcinosarcoma.